Latest Breaking News On - Study chair - Page 7 : comparemela.com

Belite Bio to Host Key Opinion Leader Webinar on RBP4 Antagonist Tinlarebant in Late-Stage Development for Stargardt Disease 1

Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009

/PRNewswire/ Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to discovering and developing novel,.

Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study with Vamorolone in Becker Muscular Dystrophy

Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce that the first patient has been dosed in a Phase 2 pilot study to assess vamorolone in Becker muscular dystrophy (BMD), funded by the U.S. Food and Drug Administration (FDA). This Phase 2 pilot study is a randomized, double-blind .

Santhera Pharmaceuticals Holding AG: Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study with Vamorolone in Becker Muscular Dystrophy

Pratteln, Switzerland, and Rockville, MD, USA, August 22, 2022 - Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce that the first patient has been dosed in a Phase 2 pilot

Jennifer Ayres receives top teaching award: 'Exemplary she has been, extraordinarily so'

She sets a standard for pedagogy at Candler School of Theology and across Emory. Exemplary Teacher of the Year Award recipient Jennifer Ayres focuses on “the full humanization of everyone in the classroom.”